Wilson Sonsini’s tax practice encompasses all areas of federal, state, and international tax law for technology, life sciences, and growth enterprises at all stages of development. We provide representation to both companies and funds in conjunction with the firm’s mergers and acquisitions practice, which involves a wide range of domestic and international transactions, including public and private acquisitions, management and leveraged buyouts, corporate restructurings, spinoffs, recapitalizations, and joint ventures.

In addition, our team counsels clients on domestic and international tax planning and represents clients in matters before the U.S. Internal Revenue Service.

See Tax Practice on

Join Our Tax Team


Looking for an opportunity to resolve new and challenging tax issues in an exciting and growing practice? Our London office is seeking a solution-focused team player with a flexible mindset and the ability to clearly and confidently communicate. You will build relationships working directly with clients as well as while providing support to our other teams. You will also be able to explain tax issues at a number of levels – switching comfortably between explaining these in pure commercial terms to investors and founders and engaging in detailed technical discussion with in-house tax team members. Your work will involve M&A transactions, venture capital finance, international business structuring for clients which are highly internationally mobile, UK/US advisory work in conjunction with the US tax practice, and funds tax. Apply now if you are UK qualified, hold or are eligible for a valid Solicitors Practising Certificate, have 2-6 years PQE or equivalent experience, and have the passion to take your career to the next level.

More Opportunities

If you would like to submit an application to Wilson Sonsini, but do not see an active posting for the office or practice you are interested in, please apply here.

  • Client Highlight

    YS Biopharma

    Wilson Sonsini represented YS Biopharma in its merger with Summit Healthcare Acquisition Corp. YS Biopharma is a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics. Summit Healthcare Acquisition Corp. is a publicly traded special purpose acquisition company.